Skip to main content

Mohan Raju's Form 4 filing

Ventyx Biosciences, Inc. (VTYX) · filed Jul 5, 2023

Accession no.
0001209191-23-041358
Filed
Jul 5, 2023
Trade date
Jul 5, 2023
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.15M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mohan RajuCIK 0001878125Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 5, 2023Common StockMOption exerciseAcquired+29,785$8.04+$239,471.41,542,911Direct
Jul 5, 2023Common StockSSaleDisposed−17,298$37.74F2−$652,826.521,525,613Direct
Jul 5, 2023Common StockSSaleDisposed−6,659$38.78F3−$258,236.021,518,954Direct
Jul 5, 2023Common StockSSaleDisposed−5,920$39.72F4−$235,142.41,513,034Direct
Jul 5, 2023Common StockSSaleDisposed−123$40.32F5−$4,959.361,512,911Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 5, 2023Common StockMOption exerciseDisposed−29,785$0.00$0425,286Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average share price of an aggregate total of 17,298 shares sold in the price range of $37.26 to $38.1912. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average share price of an aggregate total of 6,659 shares sold in the price range of $38.27 to $39.2592. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average share price of an aggregate total of 5,920 shares sold in the price range of $39.2712 to $40.2624. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average share price of an aggregate total of 123 shares sold in the price range of $40.2723 to $40.3625. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)